+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-Thrombin III Testing Market by Product (Instruments, Reagents, Software And Services), Assay Type (Chromogenic Assay, Clot-Based Assay, Immunoassay), End User, Application - Global Forecast 2025-2030- Product Image
Anti-Thrombin III Testing Market by Product (Instruments, Reagents, Software And Services), Assay Type (Chromogenic Assay, Clot-Based Assay, Immunoassay), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Anti-Thrombin III Testing Market by Product (Instruments, Reagents, Software And Services), Assay Type (Chromogenic Assay, Clot-Based Assay, Immunoassay), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015079
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Anti-Thrombin III Testing Market is undergoing significant transformation, propelled by evolving clinical demands, rapid technological advancements, and dynamic competitive strategies. Senior leaders benefit from timely insights into these market forces for effective resource allocation and strategic positioning.

Market Snapshot: Anti-Thrombin III Testing Market Growth Trajectory

The Anti-Thrombin III Testing Market grew from USD 99.84 million in 2024 to USD 109.43 million in 2025. It is expected to continue growing at a CAGR of 9.43%, reaching USD 171.53 million by 2030. This robust expansion highlights a heightened focus on coagulation disorder management and increased demand for advanced diagnostics across multiple regions.

Scope & Segmentation: Technologies, Applications, and Regional Coverage

This report covers a comprehensive segmentation of the Anti-Thrombin III Testing Market, providing deep visibility into product innovation, adoption patterns, and operational requirements. The key segments are:

  • Product Types: Automated, manual, and semi-automated instruments; consumable reagents; testing kits; software solutions; maintenance and training services.
  • Assay Types: Chromogenic assays, automated and manual clot-based assays, and immunoassays including CLIA and ELISA formats.
  • End Users: Independent diagnostic labs, private clinics, secondary and tertiary care hospitals, academic institutions, and pharmaceutical research platforms.
  • Applications: Clinical diagnostics for cardiovascular diseases, disseminated intravascular coagulation, venous thromboembolism, genetic studies, and pharmacological research.
  • Regional Coverage: North and Latin America (inclusive of U.S. states and key Latin American economies), Europe, Middle East, Africa (spanning major European nations and select Middle East/Africa countries), and Asia-Pacific (China, India, Japan, Australia, and several Southeast Asian markets).
  • Company Coverage: Profiled companies include F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, Instrumentation Laboratory Company, Sysmex Corporation, Thermo Fisher Scientific Inc., Helena Laboratories Corporation, Bio-Rad Laboratories, Inc., and Hyphen BioMed SAS.

Key Takeaways: Strategic Insights for Decision Makers

  • Automated and semi-automated platforms are increasingly central to high-throughput testing environments, reducing manual errors and expediting workflows.
  • Point-of-care solutions and portable assays are gaining ground in resource-limited regions, meeting the demand for rapid, decentralized diagnostics.
  • Regulatory reforms emphasize standardized calibration and quality assurance, creating opportunities for differentiation through compliance and reliability.
  • Collaborative partnerships between technology providers, reagent suppliers, and clinical centers are shaping tailored solutions and accelerating innovation.
  • Localized manufacturing and regional partnerships are mitigating risk in global supply chains, addressing tariff impacts and logistical challenges.
  • End users value training, support, and cloud-enabled analytics, highlighting the ongoing shift toward integrated service delivery models.

Tariff Impact: Navigating U.S. Policy and Supply Chain Pressures

The introduction of new tariff measures in the United States in 2025 has altered the cost structure for manufacturers and distributors in the anti-thrombin III testing market. Suppliers are diversifying sourcing with local manufacturing and more robust distributor relationships. Laboratories are adopting adaptive inventory models to maintain efficient operations amidst regulatory shifts and fluctuating import costs. Emphasis on remote maintenance and virtual training solutions underscores the trend toward value-added service offerings, helping labs maintain operational standards under tighter budgets.

Methodology & Data Sources: Robust Mixed-Method Approach

This analysis employs a combination of primary interviews with hematologists, laboratory administrators, and technical experts, alongside secondary research from peer-reviewed journals and industry reports. A multi-layered validation process ensures accuracy and relevance for industry stakeholders.

Why This Report Matters: Targeted Value for Senior Decision Makers

  • Empowers executives to make informed capital investments aligned with current clinical and technological trends in anti-thrombin III testing.
  • Enables strategy teams to anticipate regulatory and tariff-driven challenges and develop agile supply chain responses tailored to organizational risk profiles.
  • Provides actionable insights for R&D and business development to prioritize innovation, partnership, and market expansion initiatives.

Conclusion

This report delivers essential guidance for leaders seeking to optimize positioning amid evolving market forces. Insights into segmentation, technology, regulation, and regional trends support confident decision-making across strategic and operational domains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing integration of automated high-throughput platforms in anti-thrombin III testing to enhance laboratory efficiency
5.2. Expansion of point-of-care anti-thrombin III assays in emergency settings for rapid coagulation assessment
5.3. Increasing use of recombinant antithrombin III standards in calibrators to improve assay accuracy and consistency
5.4. Rising demand for multiplex coagulation panels including anti-thrombin III tests in personalized medicine workflows
5.5. Market penetration of portable microfluidic devices enabling bedside anti-thrombin III measurement in critical care units
5.6. Regulatory approvals for novel chromogenic assays driving wider adoption of sensitive anti-thrombin III diagnostic tools
5.7. Growing collaborations between diagnostic companies and pharmaceutical firms for integrated anti-thrombin III companion diagnostics
5.8. Emerging trend of digital health platforms integrating anti-thrombin III test data with patient electronic health records for analytics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-Thrombin III Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Automated
8.2.2. Manual
8.2.3. Semi Automated
8.3. Reagents
8.3.1. Consumables
8.3.2. Kits
8.4. Software And Services
8.4.1. Services
8.4.1.1. Maintenance
8.4.1.2. Training
8.4.2. Software
9. Anti-Thrombin III Testing Market, by Assay Type
9.1. Introduction
9.2. Chromogenic Assay
9.3. Clot-Based Assay
9.3.1. Automated Clotting Test
9.3.2. Manual Clotting Test
9.4. Immunoassay
9.4.1. Clia
9.4.2. Elisa
10. Anti-Thrombin III Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.2.1. Independent Labs
10.2.2. Private Clinics
10.3. Hospitals
10.3.1. Secondary Care
10.3.2. Tertiary Care
10.4. Research Institutes
10.4.1. Academia
10.4.2. Pharmaceutical
11. Anti-Thrombin III Testing Market, by Application
11.1. Introduction
11.2. Clinical Diagnosis
11.2.1. Cardiovascular Diseases
11.2.2. Disseminated Intravascular Coagulation
11.2.3. Venous Thromboembolism
11.3. Research
11.3.1. Genetic Studies
11.3.2. Pharmacological Research
12. Americas Anti-Thrombin III Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anti-Thrombin III Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anti-Thrombin III Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd
15.3.2. Siemens Healthineers AG
15.3.3. Abbott Laboratories
15.3.4. Danaher Corporation
15.3.5. Instrumentation Laboratory Company
15.3.6. Sysmex Corporation
15.3.7. Thermo Fisher Scientific Inc.
15.3.8. Helena Laboratories Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Hyphen BioMed SAS
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTI-THROMBIN III TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANTI-THROMBIN III TESTING MARKET: RESEARCHAI
FIGURE 24. ANTI-THROMBIN III TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. ANTI-THROMBIN III TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. ANTI-THROMBIN III TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTI-THROMBIN III TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED CLOTTING TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED CLOTTING TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL CLOTTING TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL CLOTTING TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ACADEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY GENETIC STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY GENETIC STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACOLOGICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACOLOGICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 173. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 174. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 175. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 178. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 179. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 180. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 181. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 182. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 183. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 186. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 187. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 188. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 189. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 192. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 193. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 196. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 197. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 200. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 201. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 202. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 210. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 219. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Anti-Thrombin III Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Instrumentation Laboratory Company
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Helena Laboratories Corporation
  • Bio-Rad Laboratories, Inc.
  • Hyphen BioMed SAS

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 109.43 Million
Forecasted Market Value ( USD ) by 2030 $ 171.53 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Antithrombin Market by Type (Alpha, Beta), Source (Human Plasma, Recombinant), Form, Dosage Form, Therapeutic Application, End User - Global Forecast 2025-2030 - Product Image

Antithrombin Market by Type (Alpha, Beta), Source (Human Plasma, Recombinant), Form, Dosage Form, Therapeutic Application, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
2024-2028 Global Antithrombin II Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Antithrombin II Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Antithrombin - Global Strategic Business Report - Product Image

Antithrombin - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
2025 Global Forecast for Antithrombin Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Antithrombin Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.